Auto-CD34+ Cell Therapy Improves Exercise Capacity, Angina Frequency, and Reduces Mortality in Refractory Angina
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles: